General
Preferred name
BUTYLSCOPOLAMINE
Synonyms
(-)-Scopolamine butylbromide ()
BUTYLSCOPOLAMINE BROMIDE ()
Hyoscine butylbromide ()
scopolamine butylbromide ()
Butylscopolammonium (n-) bromide ()
Scopolamine n-butylbromide ()
Scopolamine Butylbromide,(-)-Scopolamine butylbromide, Hyoscine butylbromide ()
N-butylscopolammonium ()
N-butylscopolammonium cation ()
N-butylscopolammonium ion ()
Buscolamin ()
Donopon ()
Scopolamine bromobutylate ()
Stibron ()
Buscapine ()
Amisepan ()
Joscine ()
Scopolan ()
Buscol ()
Tirantil ()
Scobutyl ()
Butylmin ()
Buscolysin ()
N-butylscopolammonium bromide ()
Sporamin ()
Scoburen ()
Hyoscine-n-butyl bromide ()
Monospan ()
Scopolamine butylbromide ()
Scobro ()
Sparicon ()
Buscapina ()
Buscopan ()
Scobutil ()
Scobron ()
Scopolamine N-butyl (bromide) ()
P&D ID
PD013105
CAS
7182-53-8
149-64-4
Tags
available
drug candidate
drug
First approval
1951
Drug Status
vet_approved
approved
investigational
Max Phase
3.0
Drug indication
bile duct disorder
Gastrointestinal disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Scopolamine butylbromide ((-)-Scopolamine butylbromide) is a competitive antagonist of mAChR (IC50: 55.3 ± 4.3 nM).
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
52
Molecular Weight
360.22
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
1
cLogP
2.23
TPSA
59.06
Fraction CSP3
0.67
Chiral centers
7.0
Largest ring
6.0
QED
0.46
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
mAChR
AChR
MOA
AChR antagonist
Pathway
Neuroscience
Source data

